Integrin modulators: a patent review

Author： Kapp Tobias G   Rechenmacher Florian   Sobahi Tariq R   Kessler Horst  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.10, 2013-10, pp. : 1273-1295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PTEN modulators: a patent review

By Boosani Chandra S   Agrawal Devendra K  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 569-580

Informa Healthcare

Access to resources Recommend Favorite

Sigma receptor modulators: a patent review

By Collina Simona   Gaggeri Raffaella   Marra Annamaria   Bassi Andrea   Negrinotti Sara   Negri Francesca   Rossi Daniela  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 597-613

Informa Healthcare

Access to resources Recommend Favorite

CXCR2 modulators: a patent review (2009 – 2013)

By Dwyer Michael P   Yu Younong  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 5, 2014-05 ,pp. : 519-534

Informa Healthcare

Access to resources Recommend Favorite

Modulators of complement activation: a patent review (2008 – 2013)

By Larghi Enrique L   Kaufman Teodoro S  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 6, 2014-06 ,pp. : 665-686

Informa Healthcare

Access to resources Recommend Favorite

αα2C-adrenoceptor modulators: a patent review

By Quaglia Wilma   Del Bello Fabio   Giannella Mario   Piergentili Alessandro   Pigini Maria  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 4, 2011-04 ,pp. : 455-481

Informa Healthcare

Access to resources Recommend Favorite